New research shows that deltaviruses can sneak into cells by hitchhiking inside other viruses, highlighting a previously ...
(Nasdaq: MIRM), a leading rare disease company, today announced completion of enrollment in the Phase 3 AZURE-1 study and completion of screening in the Phase 3 AZURE-4 study, both evaluating ...
SAN FRANCISCO (KGO) -- The Centers for Disease Control and Prevention (CDC) released new data Friday indicating the Delta variant is twice as infectious as previously thought, and a recent analysis ...
Mirum Pharmaceuticals has entered a definitive agreement to acquire Bluejay Therapeutics — a deal that, if finalized, would add brelovitug, a phase 3-stage monoclonal antibody for chronic hepatitis ...
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Week 48 endpoint analysis from the Company’s Phase 2 SOLSTICE trial for chronic hepatitis delta (CHD) ...
・Phase 2 trial showed 66% of patients achieved undetectable hepatitis delta virus RNA with Vir’s tobevibart-elebsiran combo, with no serious safety issues reported. ・Gilead’s rival therapy bulevirtide ...
"HDV should not be managed as a uniform condition. Sex-related differences matter." — Loreta A. Kondili, MD, National Center for Global Health, Italian Institute of Health, Rome “HDV is the most ...
LAS VEGAS, NEVADA -- A California couple says they were fully vaccinated, but still contracted COVID-19 while on vacation as experts say breakthrough cases are possible, especially with the delta ...
Hepatitis delta virus (HDV), a bloodborne infection that is transmitted through infected blood or other bodily fluids, was recently designated as a Group 1 carcinogen by the International Agency for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results